glp 1 multiple sclerosis Can GLP-1 Drugs Aid Management? Tirzepatide and Multiple Sclerosis: Safety
Description
The side effects are the usual suspectsgastrointestinal distress, nausea, and constipationconfirming that oral delivery does not bypass the gastric braking misery
if not, reimbursement is easy
Iron deficiency monitoring is reasonable for long-term users
In an in vitro study, tirzepatide elicited a cAMP response in a human pancreatic -cell line that was significantly higher than that observed for either GLP-1 or GIP alone, indicating a synergistic or additive activation of signaling in pancreatic -cells by GIP and GLP-1 (63)
